tiprankstipranks
Trending News
More News >
Tactile Systems Technology (TCMD)
NASDAQ:TCMD
US Market

Tactile Systems Technology (TCMD) Earnings Dates, Call Summary & Reports

Compare
427 Followers

Earnings Data

Report Date
May 11, 2026
After Close (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
-0.12
Last Year’s EPS
-0.13
Same Quarter Last Year
Based on 5 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Feb 17, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call conveyed solid operational and financial momentum—double-digit revenue growth, margin expansion, strong cash generation, successful salesforce buildout, product innovation and a strategic acquisition (LymphaTech). Management is taking prudent steps to address a new Medicare prior authorization requirement, which they expect to cause a temporary short-term drag incorporated into 2026 guidance. While operating expenses and near-term reimbursement uncertainty present modest headwinds, the company emphasized preparedness, clinical evidence progress and long-term growth catalysts.
Company Guidance
For 2026 Tactile guided total revenue of $357 million to $365 million (growth of ~8%–11% year‑over‑year), noting lymphedema and airway‑clearance businesses are expected to grow in a similar range with airway clearance modestly faster, and that Q1 growth should be higher than the balance of the year; the company expects GAAP gross margin of ~76%, GAAP operating expenses to rise ~8%–10% YoY, net interest income of about $3 million, a tax rate of 28%, and a fully diluted weighted average share count of ~22–23 million, driving adjusted EBITDA of roughly $49 million to $51 million (assuming noncash items including ~$9 million stock‑based comp, ~$3.6 million intangible amortization and ~$3.2 million depreciation); the outlook incorporates a potential short‑term market impact from CMS’s new Medicare prior‑authorization requirement for basic and advanced pneumatic compression device codes effective April 13, but management expects to navigate the change and return to market growth thereafter.
Full-Year Revenue Growth
Total revenue for FY2025 was $329.5M, up 12% year-over-year.
Strong Q4 Performance
Q4 revenue was $103.6M, up 21% year-over-year, driven by lymphedema (+16% to $89.5M) and airway clearance (+66% to $14.1M).
Expanded Gross Margin and Profitability
Full-year gross margin expanded 190 basis points to 75.9%; Q4 gross margin was 78.2% vs 75.2% in Q4 2024. Adjusted EBITDA increased 21% year-over-year to $44.8M (Q4 adjusted EBITDA $22.0M vs $16.2M prior-year).
Cash Generation and Balance Sheet Actions
Generated nearly $43M in operating cash flow for 2025; repaid $26.3M term loan, repurchased $26.5M of stock, and ended 2025 with $83.4M in cash and no outstanding borrowings.
Commercial Execution & Salesforce Buildout
Achieved year-end sales rep hiring goal, implemented a 1 account manager : 1 product specialist model, and reported improved sales productivity supported by CRM adoption.
Airway Clearance Momentum
AffloVest sales increased 66% year-over-year in Q4 and 6% sequentially; management believes they have a market-leading position in airway clearance.
Strategic Acquisition — LymphaTech
Announced acquisition of LymphaTech to add 3D digital scanning for fluid measurement and monitoring; commercialized product immediately expands product portfolio and supports TAM expansion toward undiagnosed patient population (~20M US symptomatic patients).
Clinical Evidence Progress
2-month RCT results for Flexitouch Plus published; 6-month manuscript submitted, strengthening clinical value and payer discussions for head & neck lymphedema.
Product Roadmap & Innovation
Introduced Nimbl and achieved leadership in basic compression pumps; submitted 510(k) for next-gen AffloVest and planning phased enhancements for Flexitouch (smaller, lighter, connectivity).
Operational Technology Investments
Rolled out CRM and completed phase one of AI platform for order intake and medical record review; expected to improve speed to therapy, reduce errors and enhance operating efficiency.

Tactile Systems Technology (TCMD) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

TCMD Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 11, 2026
2026 (Q1)
-0.12 / -
-0.13
Feb 17, 2026
2025 (Q4)
0.44 / 0.46
0.415.00% (+0.06)
Nov 03, 2025
2025 (Q3)
0.17 / 0.36
0.2171.43% (+0.15)
Aug 04, 2025
2025 (Q2)
0.11 / 0.14
0.18-22.22% (-0.04)
May 05, 2025
2025 (Q1)
-0.08 / -0.13
-0.05-160.00% (-0.08)
Feb 18, 2025
2024 (Q4)
0.32 / 0.40
0.385.26% (+0.02)
Nov 04, 2024
2024 (Q3)
0.18 / 0.21
0.853-75.38% (-0.64)
Aug 05, 2024
2024 (Q2)
0.14 / 0.18
0.049267.35% (+0.13)
May 06, 2024
2024 (Q1)
-0.08 / -0.05
-0.033-51.52% (-0.02)
Feb 20, 2024
2023 (Q4)
0.21 / 0.38
0.29230.14% (+0.09)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

TCMD Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 17, 2026
$28.05$33.05+17.83%
Nov 03, 2025
$15.77$22.18+40.65%
Aug 04, 2025
$9.89$12.54+26.79%
May 05, 2025
$13.94$9.90-28.98%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Tactile Systems Technology (TCMD) report earnings?
Tactile Systems Technology (TCMD) is schdueled to report earning on May 11, 2026, After Close (Confirmed).
    What is Tactile Systems Technology (TCMD) earnings time?
    Tactile Systems Technology (TCMD) earnings time is at May 11, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is TCMD EPS forecast?
          TCMD EPS forecast for the fiscal quarter 2026 (Q1) is -0.12.